Novo Integrated Sciences's gross profit for the
three
months ended in Feb. 2024 was $1.32 Mil. Novo Integrated Sciences's gross profit for the trailing twelve months (TTM) ended in Feb. 2024 was $5.51 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Competitive Comparison of Novo Integrated Sciences's Gross Profit
For the Medical Care Facilities subindustry, Novo Integrated Sciences's Gross Profit, along with its competitors' market caps and Gross Profit data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Novo Integrated Sciences's Gross Profit Distribution in the Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, Novo Integrated Sciences's Gross Profit distribution charts can be found below:
* The bar in red indicates where Novo Integrated Sciences's Gross Profit falls into.
Novo Integrated Sciences Gross Profit Calculation
Gross Profit is the different between the sale prices and the cost of buying or producing the goods.
Novo Integrated Sciences's Gross Profit for the fiscal year that ended in Aug. 2023 is calculated as
Gross Profit for the trailing twelve months (TTM) ended in Feb. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was $5.51 Mil.
Gross Profit is the numerator in the calculation of Gross Margin.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
A positive Gross Profit is only the first step for a company to make a net profit. The gross profit needs to be big enough to also cover related labor, equipment, rental, marketing/advertising, research and development and a lot of other costs in selling the products.
Novo Integrated Sciences (NAS:NVOS) Gross Profit Explanation
Warren Buffett believes that firms with excellent long term economics tend to have consistently higher margins.
Durable competitive advantage creates a high Gross Margin % because of the freedom to price in excess of cost. Companies can be categorized by their Gross Margin %
1. Greater than 40% = Durable competitive advantage
2. Less than 40% = Competition eroding margins
3. Less than 20% = no sustainable competitive advantage
Consistency of Gross Margin is key
Novo Integrated Sciences had a gross margin of 41.75% for the quarter that ended in Feb. 2024 => Durable competitive advantage
Novo Integrated Sciences Gross Profit Related Terms
Thank you for viewing the detailed overview of Novo Integrated Sciences's Gross Profit provided by GuruFocus.com. Please click on the following links to see related term pages.
Novo Integrated Sciences (Novo Integrated Sciences) Business Description
Novo Integrated Sciences Inc is a medical care company. It provides specialized physiotherapy, chiropractic care, occupational therapy, eldercare, laser therapeutics, massage therapy, acupuncture, neurological functions, kinesiology, and others. It has two reportable segments: healthcare services which generates majority of the revenue, and product sales.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
Portfolio Contest
NVOS has been successfully added to your 